GB0514530D0 - Pharmaceutical agent - Google Patents
Pharmaceutical agentInfo
- Publication number
- GB0514530D0 GB0514530D0 GB0514530A GB0514530A GB0514530D0 GB 0514530 D0 GB0514530 D0 GB 0514530D0 GB 0514530 A GB0514530 A GB 0514530A GB 0514530 A GB0514530 A GB 0514530A GB 0514530 D0 GB0514530 D0 GB 0514530D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0514530A GB0514530D0 (en) | 2005-07-15 | 2005-07-15 | Pharmaceutical agent |
PCT/GB2005/004502 WO2006056772A2 (en) | 2004-11-23 | 2005-11-23 | Salts of quetiapine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0514530A GB0514530D0 (en) | 2005-07-15 | 2005-07-15 | Pharmaceutical agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0514530D0 true GB0514530D0 (en) | 2005-08-24 |
Family
ID=34897258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0514530A Ceased GB0514530D0 (en) | 2004-11-23 | 2005-07-15 | Pharmaceutical agent |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0514530D0 (en) |
-
2005
- 2005-07-15 GB GB0514530A patent/GB0514530D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2008004533A0 (en) | Pharmaceutical combination | |
PL2175273T3 (en) | Kokumi-imparting agent | |
GB0501999D0 (en) | Pharmaceutical compounds | |
GB0520657D0 (en) | Pharmaceutical compounds | |
IL186336A0 (en) | Pharmaceutical composition | |
GB0520656D0 (en) | Pharmaceutical compounds | |
GB0516091D0 (en) | Therapeutic agent | |
EP1927347A4 (en) | Bitterness-reducing agent | |
EP1889660A4 (en) | Ozone-decomposing agent | |
EP1852117A4 (en) | Pharmaceutical agent comprising solifenacin | |
ZA200804666B (en) | Pharmaceutical combination | |
GB0512643D0 (en) | Pharmaceutical compounds | |
TWI372053B (en) | Combination drug | |
ZA200705612B (en) | Pharmaceutical compounds | |
GB0512246D0 (en) | Novel pharmaceutical | |
GB0501475D0 (en) | Pharmaceutical compounds | |
GB0508153D0 (en) | Therapeutic agent | |
GB0514530D0 (en) | Pharmaceutical agent | |
GB0515315D0 (en) | Pharmaceutical agents | |
GB0500826D0 (en) | Pharmaceutical use | |
GB0515304D0 (en) | Medicinal agents | |
GB0500691D0 (en) | Pharmaceutical combinations | |
GB0515937D0 (en) | Pharmaceutical formulation | |
GB0511801D0 (en) | Pharmaceutical composition | |
ZA200803112B (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |